Navegar por autor "Antón Aparicio, Luis Miguel"

A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results

2012- Antón Aparicio, Luis Miguel

Biological influence of Hakai in cancer: a 10-year review

2012- Valladares Ayerbes, Manuel; Blanco Calvo, Moisés; Antón Aparicio, Luis Miguel; Figueroa Conde-Valvís, Angélica; Figueroa Conde-Valvís, Angélica [et al.]

Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program

2014- Antón Aparicio, Luis Miguel

CABAZITAXEL PLUS PREDNISONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: ANALYSIS BY AGE GROUP

2015- Antón Aparicio, Luis Miguel

Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer

2014- Valladares Ayerbes, Manuel; Haz Conde, María del Mar; Blanco Calvo, Moisés; Antón Aparicio, Luis Miguel; Reboredo Lopez, Margarita; [et al.]

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

2012- Valladares Ayerbes, Manuel; Reboredo Lopez, Margarita; Medina Villaamil, Vanessa; Iglesias Díaz, Pilar; Lorenzo Patiño, María José; [et al.]

Crossing Paths in Human Renal Cell Carcinoma (hRCC)

2012- Antón Aparicio, Luis Miguel; Aparicio Gallego, Guadalupe; Medina Villaamil, Vanessa; Santamarina Cainzos, Isabel

Effect of a microtubule-targeting drug on cell-cell contacts in bladder epithelial tumour cells

2014- Valladares Ayerbes, Manuel; Haz Conde, María del Mar; Blanco Calvo, Moisés; Antón Aparicio, Luis Miguel; Figueroa Conde-Valvís, Angélica [et al.]

Efficacy and Safety of somatuline autogel in combination with molecular targeted therapies (MTT) in neuroendocrine tumors (NETS).

2012- Antón Aparicio, Luis Miguel

Evaluation of the Adenocarcinoma-Associated Gene AGR2 and the Intestinal Stem Cell Marker LGR5 as Biomarkers in Colorectal Cancer

2012- Valladares Ayerbes, Manuel; Blanco Calvo, Moisés; Reboredo Lopez, Margarita; Lorenzo Patiño, María José; Iglesias Díaz, Pilar; [et al.]

Expression of Notch family members in stage IV renal cell carcinoma tumors: Notch1 as medium-risk prognosis factor

2012- Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Firvida Perez, Jose Luis; León Mateos, Luis Ángel; [et al.]

Hakai reduces cell-substratum adhesion and increases epithelial cell invasion

2011- RODRIGUEZ REGUEIRO, TERESA; Valladares Ayerbes, Manuel; Haz Conde, María del Mar; Antón Aparicio, Luis Miguel; Figueroa Conde-Valvís, Angélica [et al.]

Hierarchical clustering analysis of tissue microarray immunostaining data on renal cell carcinomas

2011- Valladares Ayerbes, Manuel; Haz Conde, María del Mar; Antón Aparicio, Luis Miguel; Aparicio Gallego, Guadalupe; Medina Villaamil, Vanessa; [et al.]

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience

2012- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; [et al.]

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel

2014- Antón Aparicio, Luis Miguel; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; [et al.]

MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients

2012- Antón Aparicio, Luis Miguel

MicroRNA profile and KRAS status in metastatic colorectal cancer

2011- Valladares Ayerbes, Manuel; Haz Conde, María del Mar; Blanco Calvo, Moisés; Antón Aparicio, Luis Miguel; Reboredo Lopez, Margarita; [et al.]

MicroRNAs as emerging biomarkers for micrometastasis detection in genitourinary tumors

2011- Valladares Ayerbes, Manuel; Antolín Novoa, Silvia; Antón Aparicio, Luis Miguel; Reboredo Lopez, Margarita; Aparicio Gallego, Guadalupe; [et al.]

miR-203 regulates cell proliferation through its influence on Hakai expression

2012- Abella Cajigal, Vanesa; Valladares Ayerbes, Manuel; Rodríguez, Teresa; Haz Conde, María del Mar; Blanco Calvo, Moisés; [et al.]

Molecular basis of hypertension side effects induced by sunitinib

2011- Antón Aparicio, Luis Miguel; León Mateos, Luis Ángel

Repositorio digital RUNA

Navegar por autor "Antón Aparicio, Luis Miguel"

A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results ﻿

Biological influence of Hakai in cancer: a 10-year review ﻿

Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program ﻿

CABAZITAXEL PLUS PREDNISONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: ANALYSIS BY AGE GROUP ﻿

Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer ﻿

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer ﻿

Crossing Paths in Human Renal Cell Carcinoma (hRCC) ﻿

Effect of a microtubule-targeting drug on cell-cell contacts in bladder epithelial tumour cells ﻿

Efficacy and Safety of somatuline autogel in combination with molecular targeted therapies (MTT) in neuroendocrine tumors (NETS). ﻿

Evaluation of the Adenocarcinoma-Associated Gene AGR2 and the Intestinal Stem Cell Marker LGR5 as Biomarkers in Colorectal Cancer ﻿

Expression of Notch family members in stage IV renal cell carcinoma tumors: Notch1 as medium-risk prognosis factor ﻿

Hakai reduces cell-substratum adhesion and increases epithelial cell invasion ﻿

Hierarchical clustering analysis of tissue microarray immunostaining data on renal cell carcinomas ﻿

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience ﻿

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel ﻿

MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients ﻿

MicroRNA profile and KRAS status in metastatic colorectal cancer ﻿

MicroRNAs as emerging biomarkers for micrometastasis detection in genitourinary tumors ﻿

miR-203 regulates cell proliferation through its influence on Hakai expression ﻿

Molecular basis of hypertension side effects induced by sunitinib ﻿

A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results

Biological influence of Hakai in cancer: a 10-year review

Cabazitaxel for metastatic castration-resistant prostate cancer: Safety data from the Spanish expanded access program

CABAZITAXEL PLUS PREDNISONE IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (mCRPC) PREVIOUSLY TREATED WITH DOCETAXEL: ANALYSIS BY AGE GROUP

Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer

Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer

Crossing Paths in Human Renal Cell Carcinoma (hRCC)

Effect of a microtubule-targeting drug on cell-cell contacts in bladder epithelial tumour cells

Efficacy and Safety of somatuline autogel in combination with molecular targeted therapies (MTT) in neuroendocrine tumors (NETS).

Evaluation of the Adenocarcinoma-Associated Gene AGR2 and the Intestinal Stem Cell Marker LGR5 as Biomarkers in Colorectal Cancer

Expression of Notch family members in stage IV renal cell carcinoma tumors: Notch1 as medium-risk prognosis factor

Hakai reduces cell-substratum adhesion and increases epithelial cell invasion

Hierarchical clustering analysis of tissue microarray immunostaining data on renal cell carcinomas

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel

MicroRNA expression profiling of peripheral blood samples predicts resistance to first-line sunitinib in advanced renal cell carcinoma patients

MicroRNA profile and KRAS status in metastatic colorectal cancer

MicroRNAs as emerging biomarkers for micrometastasis detection in genitourinary tumors

miR-203 regulates cell proliferation through its influence on Hakai expression

Molecular basis of hypertension side effects induced by sunitinib